Eris Lifesciences

1,397.05
+3.00
(0.22%)
Market Cap (₹ Cr.)
₹18,929
52 Week High
1,522.05
Book Value
₹190
52 Week Low
804.00
PE Ratio
49.77
PB Ratio
7.32
PE for Sector
57.62
PB for Sector
19.92
ROE
16.85 %
ROCE
10.87 %
Dividend Yield
0.00 %
EPS
₹27.95
Industry
Pharmaceuticals
Sector
Pharmaceuticals - Indian - Formulations
comparison:

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Growth Rate
Revenue Growth
19.85 %
Net Income Growth
6.12 %
Cash Flow Change
66.59 %
ROE
-26.86 %
ROCE
-26.75 %
EBITDA Margin (Avg.)
6.40 %

Financial Results

Quarterly Financials
Jun 2016
Sept 2016
Dec 2016
Mar 2017
Jun 2017
Sept 2017
Dec 2017
Mar 2018
Jun 2018
Sept 2018
Dec 2018
Mar 2019
Jun 2019
Sept 2019
Dec 2019
Mar 2020
Jun 2020
Sept 2020
Dec 2020
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Revenue
190
201
173
174
169
229
188
202
231
247
241
210
265
278
262
230
263
306
291
260
313
330
310
291
332
362
335
319
415
417
328
362
462
Expenses
113
121
96
112
93
127
103
122
142
144
140
137
162
166
179
158
161
183
184
163
184
186
182
181
203
214
206
203
256
265
250
262
333
EBITDA
76
80
77
62
76
102
85
80
89
103
101
74
103
112
83
72
101
122
107
97
129
145
129
111
130
147
130
116
160
151
78
100
129
Operating Profit %
39 %
38 %
43 %
33 %
43 %
38 %
43 %
36 %
36 %
39 %
38 %
30 %
38 %
38 %
28 %
30 %
37 %
39 %
35 %
36 %
39 %
41 %
39 %
35 %
37 %
39 %
37 %
34 %
37 %
34 %
21 %
21 %
26 %
Depreciation
5
5
6
6
4
5
6
8
6
7
8
10
10
10
11
13
9
9
9
10
11
12
14
15
15
16
17
17
20
25
28
29
46
Interest
0
1
0
0
0
0
3
8
7
6
5
4
1
0
0
0
0
0
0
0
0
1
1
1
7
7
3
3
7
7
15
29
56
Profit Before Tax
72
74
72
56
72
98
77
65
75
90
87
59
92
101
71
59
92
113
97
86
117
132
114
95
107
124
110
96
133
120
35
42
27
Tax
11
15
15
11
16
21
17
14
17
20
19
13
20
14
13
10
16
20
17
17
21
29
23
7
19
21
19
17
22
22
6
8
5
Net Profit
62
66
67
53
70
92
74
58
70
84
79
52
82
92
63
55
87
105
89
69
107
120
104
87
96
115
99
88
111
118
32
40
17
EPS in ₹
45.22
4.82
4.89
3.82
5.09
6.71
5.38
4.18
5.10
6.10
5.74
3.81
5.96
6.66
4.55
4.05
6.42
7.77
6.52
5.11
7.86
8.81
7.66
6.38
7.03
8.47
7.31
6.46
8.14
8.66
2.33
2.90
1.25

Balance Sheet

Balance Sheet
2016
2017
2018
2019
2020
2021
2022
2023
2024
Total Assets
398
657
1,370
1,470
1,483
1,755
2,150
2,784
5,350
Fixed Assets
65
92
490
484
601
584
642
898
1,516
Current Assets
237
213
316
550
450
424
580
552
1,877
Capital Work in Progress
0
0
0
3
4
2
3
0
1
Investments
144
381
546
580
320
531
778
997
1,619
Other Assets
189
184
335
403
558
638
728
889
2,214
Total Liabilities
96
82
502
314
183
179
232
562
2,826
Current Liabilities
71
61
210
291
149
144
166
284
2,262
Non Current Liabilities
25
21
292
24
34
35
66
278
564
Total Equity
302
575
868
1,156
1,300
1,575
1,919
2,222
2,524
Reserve & Surplus
302
561
854
1,142
1,286
1,562
1,905
2,208
2,510
Share Capital
0
14
14
14
14
14
14
14
14

Cash Flow

Cash Flow
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Net Cash Flow
-1
4
-6
7
-2
58
-34
13
3
4
Investing Activities
-94
-45
-199
-593
2
127
-348
-268
-513
-2,492
Operating Activities
92
133
210
236
216
265
395
369
322
336
Financing Activities
1
-84
-18
363
-221
-334
-81
-88
194
2,160

Share Holding

% Holding
Jan 2020
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Promoter
55.55 %
54.13 %
52.69 %
52.68 %
52.66 %
52.66 %
52.30 %
52.29 %
52.70 %
52.86 %
52.86 %
54.91 %
54.90 %
54.90 %
54.88 %
FIIs
10.19 %
12.42 %
13.49 %
13.60 %
13.34 %
13.31 %
15.35 %
15.39 %
15.50 %
14.86 %
13.78 %
13.20 %
13.14 %
14.27 %
14.59 %
DIIs
11.18 %
9.67 %
10.05 %
9.94 %
10.37 %
10.51 %
10.66 %
10.68 %
9.94 %
10.02 %
10.74 %
14.53 %
14.56 %
15.63 %
16.23 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
23.08 %
23.78 %
23.77 %
23.78 %
23.62 %
23.52 %
21.69 %
21.64 %
21.85 %
22.26 %
22.63 %
17.37 %
17.41 %
15.19 %
14.30 %

Peer Comparison Compare Peers on Screener

Competitors LTP Market Cap (₹ Cr.) P/E Ratio Revenue (₹ Cr.) YoY Revenue Growth % Net Profit (₹ Cr.) YoY Profit Growth % RSI
3,359.60 1,16,815.97 69.82 10,785.75 11.59 1,656 20.90 47.50
3,121.15 39,351.06 46.09 4,293.31 11.77 816 18.09 49.72
1,841.50 30,430.47 42.14 5,834.96 50.97 772 -25.94 37.24
1,397.05 18,928.93 49.77 2,032.96 19.85 397 -4.52 62.53
1,965.50 15,241.11 31.91 1,761.04 15.65 461 19.85 57.70
281.22 13,424.98 40.20 2,227.83 16.55 315 26.45 67.40
901.90 8,720.99 212.33 1,159.77 8.64 32 1,091.53 73.96
1,406.80 3,353.63 100.45 207.35 40.06 34 - 55.67
804.90 2,253.29 52.91 192.42 12.50 21 -34.09 56.41
23.18 2,241.90 79.50 238.85 3.11 20 73.41 56.92

Corporate Action

Technical Indicators

RSI(14)
Neutral
62.53
ATR(14)
Less Volatile
52.18
STOCH(9,6)
Neutral
33.88
STOCH RSI(14)
Oversold
2.40
MACD(12,26)
Bearish
-14.44
ADX(14)
Strong Trend
43.98
UO(9)
Bearish
49.08
ROC(12)
Downtrend And Accelerating
-1.67
WillR(14)
Neutral
-62.80